On Dec. 7, American Herbal Products Association (AHPA) Chief Science Officer Steven Dentali, Ph.D., represented AHPA at a workshop hosted by the U.S. Department of Commerce to meet with Chinese regulatory officials and pharmacopeia experts, whose presence was organized by the U.S. Pharmacopeia (USP), on the global trade in dietary supplements and pharmaceuticals. Also in attendance were representatives of other dietary supplement associations, Department of Commerce officials, and representatives from U.S. pharmaceutical companies and associations.
The event, the second held, took place at the request of USP for the purpose of providing a forum of exchange between Chinese regulatory authorities and representatives of the U.S. supplement and pharmaceutical industries. Dr. Dentali's presentation included a review of the U.S. botanical industry. Other presentations included topics such as ingredient procurement and quality control, registration and standardization of Traditional Chinese Medicines in China, control of non-dietary ingredients in dietary supplements, and USP's monograph modernization process.
"For the second year in a row it was my pleasure to address the Chinese Pharmacopoeia Commission - U.S. Pharmacopeial Convention Executive Training Program and tell attendees about AHPA and the work we do," said Dentali. "It was an honor to be heard by about two dozen Chinese director or deputy director generals involved with food and drug control on topics such as AHPA's standard-setting activities, interactions with other organizations, and our establishment of several industry guidance documents. I also gave them a brief overview of the U.S. herbal industry and presented concepts on extract standardization, added ingredients, and the relation of marker compounds to bioactivity."